Suppr超能文献

人乳头瘤病毒 16 型感染自然史中的病毒载量:巢式病例对照研究。

Viral load in the natural history of human papillomavirus type 16 infection: a nested case-control study.

机构信息

Department of Pathology, School of Medicine, University of Washington, Seattle, Washington, USA.

出版信息

J Infect Dis. 2011 May 15;203(10):1425-33. doi: 10.1093/infdis/jir049. Epub 2011 Mar 16.

Abstract

BACKGROUND

Viral load may influence the course of human papillomavirus type 16 (HPV-16) infection.

METHODS

This case-control study was nested within the 2-year Atypical Squamous Cells of Undetermined Significance and Low-Grade Squamous Intraepithelial Lesion Triage Study, in which women were followed semiannually for HPV and cervical intraepithelial neoplasia (CIN). Case patients (n = 62) were women diagnosed with CIN3 following HPV-16-positive detection at a follow-up visit. HPV-16-positive controls (n = 152) without CIN2 or CIN3 were matched to cases based on the follow-up visit in which viral load was measured. Real-time polymerase chain reaction was used for HPV-16 DNA quantification.

RESULTS

The risk of CIN3 increased with increasing HPV-16 DNA load at the follow-up visit (odds ratio, 1.63; 95% confidence interval, 1.33-1.99 per 1 log(10) unit increase); the association was not affected by whether HPV-16 was present at enrollment. When HPV-16 was present at both enrollment and follow-up, viral load remained high among cases (P = .77) but decreased substantially among controls (P = .004). Among women with HPV-16 found initially during follow-up, viral load in the first HPV-16-positive sample was associated with short-term persistence; load was higher in those with infection, compared with those without infection, 1 visit after the initial positivity (P = .001).

CONCLUSIONS

Viral load of newly detected infections and changes in viral load predict persistence and progression of HPV-16 infections.

摘要

背景

病毒载量可能会影响人乳头瘤病毒 16 型(HPV-16)感染的进程。

方法

本病例对照研究嵌套于为期 2 年的非典型意义不明确的鳞状细胞和低级别鳞状上皮内病变分流研究中,该研究中女性每半年接受一次 HPV 和宫颈上皮内瘤变(CIN)随访。病例患者(n=62)为在随访时 HPV-16 阳性检测后诊断为 CIN3 的女性。HPV-16 阳性对照(n=152)无 CIN2 或 CIN3,与病例根据测量病毒载量的随访时间相匹配。采用实时聚合酶链反应进行 HPV-16 DNA 定量。

结果

随访时 HPV-16 DNA 载量增加与 CIN3 的风险增加相关(比值比,1.63;95%置信区间,1.33-1.99,每增加 1 个 log10 单位);该关联不受 HPV-16 是在入组时存在还是在随访时存在的影响。当 HPV-16 既在入组时存在又在随访时存在时,病例中病毒载量仍保持较高水平(P=.77),但在对照组中病毒载量显著降低(P=.004)。在最初随访期间发现 HPV-16 的女性中,第一个 HPV-16 阳性样本中的病毒载量与短期持续性相关;与无感染相比,在感染女性中,在最初阳性后 1 次就诊时病毒载量更高(P=.001)。

结论

新发现感染的病毒载量和病毒载量的变化可预测 HPV-16 感染的持续性和进展。

相似文献

1
Viral load in the natural history of human papillomavirus type 16 infection: a nested case-control study.
J Infect Dis. 2011 May 15;203(10):1425-33. doi: 10.1093/infdis/jir049. Epub 2011 Mar 16.
5
Changes in type-specific human papillomavirus load predict progression to cervical cancer.
J Cell Mol Med. 2012 Dec;16(12):3096-104. doi: 10.1111/j.1582-4934.2012.01631.x.
6
Changes in DNA Level of Oncogenic Human Papillomaviruses Other Than Types 16 and 18 in Relation to Risk of Cervical Intraepithelial Neoplasia Grades 2 and 3.
Cancer Epidemiol Biomarkers Prev. 2019 Aug;28(8):1388-1394. doi: 10.1158/1055-9965.EPI-18-0802. Epub 2019 May 17.
8
Association of Human Papillomavirus 31 DNA Load with Risk of Cervical Intraepithelial Neoplasia Grades 2 and 3.
J Clin Microbiol. 2015 Nov;53(11):3451-7. doi: 10.1128/JCM.01279-15. Epub 2015 Aug 19.

引用本文的文献

1
HPV16/HPV58 viral load is non-linearly correlated with cervical lesions and can be used as a triage marker.
Infect Agent Cancer. 2025 Jul 22;20(1):48. doi: 10.1186/s13027-025-00684-w.
5
The clinical effectiveness of one-dose vaccination with an HPV vaccine: A meta-analysis of 902,368 vaccinated women.
PLoS One. 2024 Jan 5;19(1):e0290808. doi: 10.1371/journal.pone.0290808. eCollection 2024.
6
A rapid HPV typing assay to support global cervical cancer screening and risk-based management: A cross-sectional study.
Int J Cancer. 2024 Jan 15;154(2):241-250. doi: 10.1002/ijc.34698. Epub 2023 Sep 29.
7
Characterization of HPV subtypes in invasive cervical cancer in Botswana patients using a pan-pathogen microarray technology.
Tumour Virus Res. 2023 Jun;15:200262. doi: 10.1016/j.tvr.2023.200262. Epub 2023 May 19.
8
Stress keratin 17 and estrogen support viral persistence and modulate the immune environment during cervicovaginal murine papillomavirus infection.
Proc Natl Acad Sci U S A. 2023 Mar 21;120(12):e2214225120. doi: 10.1073/pnas.2214225120. Epub 2023 Mar 14.
9
A comprehensive HPV-STI NGS assay for detection of 29 HPV types and 14 non-HPV sexually transmitted infections.
Infect Agent Cancer. 2022 Mar 21;17(1):9. doi: 10.1186/s13027-022-00420-8.

本文引用的文献

1
Is human papillomavirus viral load a clinically useful predictive marker? A longitudinal study.
Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):832-7. doi: 10.1158/1055-9965.EPI-09-0838. Epub 2010 Mar 3.
5
Human papillomavirus type 16 (HPV-16) viral load and persistence of HPV-16 infection in women infected or at risk for HIV.
J Clin Virol. 2008 Nov;43(3):307-12. doi: 10.1016/j.jcv.2008.07.013. Epub 2008 Sep 10.
8
Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections.
J Natl Cancer Inst. 2008 Apr 2;100(7):513-7. doi: 10.1093/jnci/djn044. Epub 2008 Mar 25.
9
The log multinomial regression model for nominal outcomes with more than two attributes.
Biom J. 2007 Dec;49(6):889-902. doi: 10.1002/bimj.200610377.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验